Cover Image
ISSN: 2148-5372 e-ISSN: 2980-1443

Author Guidelines

THE TURKISH JOURNAL OF GYNECOLOGIC ONCOLOGY

 

INSTRUCTIONS TO AUTHORS

 

  • The Turkish Journal of Gynecologic Oncology is the scientific publication of the Turkish Society of Gynecologic Oncology. It is an international journal that publishes original research articles based on clinical and experimental studies, reviews, original case reports, and letters to the editor in the field of gynecologic cancers.
  • The Turkish Journal of Gynecologic Oncology is published three times a year. The languages of publication are Turkish and English. Manuscripts related to all disciplines involved in gynecologic oncology, including gynecologic oncology surgery, radiotherapy, chemotherapy, pathology, cytology, endocrinology, genetics, molecular biology, and epidemiology, are considered for publication. Submitted manuscripts are evaluated by two blinded reviewers for suitability for publication and are subsequently accepted or rejected based on the peer-review process.
  • Manuscripts should be prepared according to the following instructions and submitted through the journal's online submission system at https://dergipark.org.tr/trsgo.
  • Since the authors are responsible for reaching consensus regarding the content of the manuscript, all authors must approve the submitted version and provide their commitment that the manuscript has not been previously published elsewhere and is not being considered simultaneously by another journal. Papers that have previously been presented at a scientific meeting may be considered for publication, provided that the name, location, and date of the meeting are clearly stated.
  • Manuscripts and tables should be submitted as Microsoft Word files. Figures, graphs, and photographs should be submitted separately as JPEG files and should not be embedded in the main manuscript file. A cover letter signed by all authors should also be scanned and submitted.

              MANUSCRIPT PREPARATION

  • Manuscripts should be prepared in Turkish or English using Times New Roman, 12-point font, with 2.5-cm marginson all sides. All pages should be numbered consecutively, beginning with the title page, with page numbers placed in the upper right corner.
  • Manuscripts should be organized in the following order:

               Title Page

  • The title page should be prepared as a separate file and should include the following information:
  • Type of manuscript and full title of the study
  • Turkish and English short titles (maximum 60 characters)
  • Full names of all authors (with surnames in capital letters), academic titles, institutional affiliations and departments, e-mail addresses, and telephone numbers
  • Full correspondence address of the corresponding author, including telephone, fax, and e-mail information
  • A statement regarding whether any conflict of interest exists among the authors
  • Information on financial support, including the name of the funding institution or organization, if applicable
  • Information regarding ethical approval, including the name of the ethics committee, institution, and approval number; if ethical approval was not obtained, the reason should be stated
  • Individual contributions of each author
  • Information on whether any part of the study has previously been presented or published at a congress, symposium, or other scientific/public platform
  • A statement confirming whether the manuscript has been submitted to or is currently under consideration by another journal

The English versions of all the above information should also be provided in the same file.

For studies involving human participants, the manuscript should state whether ethics committee approval was obtained and whether the study was conducted in accordance with the principles of the Declaration of Helsinki, as revised in 2000. If ethics committee approval was not obtained, the reason must be clearly stated.

The corresponding author must be clearly identified, and complete contact information must be provided.

               Abstract Page

  • The abstract page should include:
  • The Turkish title, followed by the Turkish abstract and keywords (not mandatory for manuscripts submitted from outside Türkiye)
  • The English title, followed by the English abstract and keywords
  • Abstracts should not exceed 250 words.
  • For original observational and experimental studies, the abstract should include the following headings:
  • Objective, Materials and Methods, Results, and Discussion or Conclusion.
  • For case reports, the abstract should include:
  • Objective, Case Report, and Discussion or Conclusion.
  • Abstracts of review articles should provide a brief summary of the main points of the review. Letters to the editor should not include an abstract.

               Keywords

  • A maximum of six keywords should be provided for indexing purposes. Authors are encouraged to use terms that comply with the Medical Subject Headings (MeSH) list of Index Medicus.

               Acknowledgments

  • An acknowledgment section may be included when applicable.

              Main Text

For observational and experimental studies, the main text should consist of the following sections:

Introduction, Materials and Methods, Results, Discussion or Conclusion, and References.

Case reports should include:

Introduction, Case Report, and Discussion.

Review articles and letters to the editor may be organized according to their specific content and may include appropriate subheadings.

Tables, figures, and images may be included in the main manuscript file or submitted separately as JPEG or Word files.

The number of authors should not exceed 10 for original research articles, 5 for case reports, and 5 for review articles and letters to the editor. A larger number of authors may be permitted for multicenter studies.

               Introduction

  • The rationale for conducting the study and its objective should be stated briefly, with reference only to the most relevant literature.

               Materials and Methods

  • All details of the study should be clearly described. Clinical, technical, or experimental methods should be presented in sufficient detail to allow the study to be reproduced. Previously published methods should be appropriately referenced. All relevant ethical approvals and permissions should be clearly stated.

               Results

  • The findings should be presented without interpretation or commentary. The data presented in tables, figures, or graphs should not be unnecessarily repeated in the text.

               Discussion

  • The findings should be discussed in relation to the results of previous studies by other authors. The implications of the findings for experimental research and/or clinical practice should also be addressed.

              References

  • References should be prepared in accordance with the Vancouver citation style. References should be numbered consecutively in the order in which they are first cited in the manuscript and indicated in the text using Arabic numerals in parentheses. For example: (1), (2,3), (4-6). References cited for the first time in tables and figures should also be cited in the main text where the relevant table or figure is described.
  • Presentations, unpublished observations, and personal communications should not be used as references. Articles that have been accepted for publication but have not yet been published may be cited; in such cases, the journal name should be provided and the expression “in press” should be included at the end of the reference.
  • References should be verified by the authors against the original sources. Journal titles should be abbreviated according to the standards of Index Medicus. All authors should be listed in the reference list. If there are more than six authors, the first six authors should be listed, followed by “et al.”
  • A DOI (Digital Object Identifier) should be provided for all references for which a DOI is available. The DOI should be given at the end of the reference, preferably in the https://doi.org/ format.

              Tables

  • Tables should be uploaded to the submission system as separate files. Tables should complement the manuscript and should not duplicate data presented in the text.
  • Each table should be presented on a separate page and numbered consecutively. Explanatory information should be provided as footnotes, and footnotes should be indicated using superscript letters. Tables should be numbered according to the order in which they are cited in the manuscript.

               Figures, Graphs, and Photographs

  • The same data should be presented either as a table or as a graph, but not both.
  • All figures should be numbered consecutively using Arabic numerals and submitted separately from the main manuscript. The publisher reserves the right to reduce or enlarge these materials as necessary.
  • Arrows, letters, and numbers should be professionally placed. If this is not possible, they should be placed on an overlay rather than directly on the original figure or photograph.
  • Figure legends should be concise and should not exceed four or five lines. Statements such as “see the manuscript for explanation” should be avoided.
  • A separate page containing a list of tables, figures, and graphs should be provided.
  • Proofs
  • Proofs will be sent only to the corresponding author and should be returned as soon as possible after making only the necessary corrections. No new material or additions should be introduced at the proof stage.

              Copyright and Responsibility

The copyright of articles published in the journal belongs to the Turkish Society of Gynecologic Oncology upon acceptance for publication.

The authors are responsible for the ethical and scientific content of their manuscripts. No royalty or copyright fee is paid to authors.

Manuscripts that do not comply with the requirements specified above will be returned to the authors for completion of the missing requirements before further consideration.

 

Last Update Time: August 18, 2026